Here, we identify SMC4 as a multifunctional oncoprotein driving glioma progression through dual mechanisms: activation of TGF-β/Smad-mediated metastasis and LDHA-dependent metabolic reprogramming. This evidence concerns the gene TGFB1 and glioma.